// App-Quantinova.ai

LB314 : A Mechanistic Model Combines Macrophage Senescence And Cycles Of Metabolic Reprogramming To Explain Progression Of Multiple Sclerosis

Researchers

Presenter

  • Z. Bocskei

Principal Investigators

  • M. Adriani

  • G. A. Robinson

  • K. E. Waddington

  • E. C. Jury

  • V. Mikol

Medical Centers

  • Translational Sciences Platform, Sanofi R&D, Chilly Mazarin, France

  • Department of Medical Oncology, University College London Hospital, London, United Kingdom

  • Centre for Rheumatology, University College London Division of Medicine, London, United Kingdom

Locations

  • France

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Multiple Sclerosis

Biomarkers

  • ATP-binding cassette super-family G member 2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved